Syntheses, structures, and antimicrobial activities of light-stable and di- and mononuclear silver(I) carboxylate complexes composed of triphenylphosphine, and chiral and racemic forms of 2-pyrrolidone-5-carboxylic acid (H 2pyrrld). A variety of Ag-o bonding modes in the silver(I) complexes constructed with hard oxygen and soft phosphorus atoms

Bulletin of the Chemical Society of Japan

Volumn 78, Issue 11, 2005, Pages 1953-1962

  Noguchi, Ryusuke ^a   Sugie, Akiyoshi ^a   Okamoto, Yohei ^a   Hara, Akihiro ^a   Nomiya, Kenji ^a  

^a KANAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONDING MODES; ENANTIOMERIC COMPLEXES; TRIPHENYLPHOSPHINE; WATER-SUSPENSION SYSTEM;

COMPLEXATION; MICROBIOLOGY; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SILVER COMPOUNDS; SYNTHESIS (CHEMICAL); X RAY CRYSTALLOGRAPHY;

ORGANOMETALLICS;

CARBOXYLIC ACID DERIVATIVE; OXYGEN DERIVATIVE; PHOSPHORUS DERIVATIVE; PYROGLUTAMIC ACID; SILVER CARBOXYLIC ACID; SILVER DERIVATIVE; TRIPHENYLPHOSPHINE; TRIPHENYLPHOSPHINE SILVER; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM; CHEMICAL BOND; CHIRALITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RACEMIC MIXTURE; X RAY CRYSTALLOGRAPHY; YEAST;

EID: 29544442652     PISSN: 00092673     EISSN: 13480634     Source Type: Journal    
DOI: 10.1246/bcsj.78.1953     Document Type: Article

References (37)

1. a) M. C. Gimeno and A. Laguna, "Comprehensive Coordination Chemistry II," Elsevier, Oxford (2004), Vol. 6, p. 911.
2. b) C. F. Shaw, III, Chem. Rev., 99, 2589 (1999).
3. c) C. F. Shaw, III, "Uses of Inorganic Chemistry in Medicine," ed by N. P. Farrell, RSC, U. K. (1999), Chap. 3, p. 26.
4. d) W. Kaim and B. Schwederski, "Bioinorganic Chemistry: Inorganic Elements in the Chemistry of Life," John Wiley, New York (1994), p. 373.
5. e) M. J. Abrams and B. A. Murrer, Science, 261, 725 (1993).
6. f) E. J. Corey, M. Mehrotra, and A. U. Khan, Science, 236, 68 (1987).
7. g) M. Munakata, L. P. Wu, and G. L. Ning, Coord. Chem. Rev., 198, 171 (2000).
8. a) R. V. Parish, Interdiscip. Sci. Rev., 17, 221 (1992).
9. b) R. J. Sue and P. J. Sadler, Met.-Based Drugs, 1, 107 (1994).
10. c) D. de Vos, P. Clements, S. M. Pyke, D. R. Smyth, and E. R. T. Tiekink, Met.-Based Drugs, 6, 31 (1999).
11. d) M. J. McKeage, P. Papathanasiou, G. Salem, A. Sjaarda, G. F. Swiegers, P. Waring, and S. B. Wild, Met.-Based Drugs, 5, 217 (1998).
12. a) F. Novelli, M. Recine, F. Sparatore, and C. Juliano, Il Farmaco, 54, 232 (1999).
13. b) S. P. Fricker, Gold Bull., 29, 53 (1996).
14. c) A. M. Elsome, J. M. T. Hamilton-Miller, W. Brumfitt, and W. C. Noble, J. Antimicrob. Chemother., 37, 911 (1996).
15. d) S. J. Berners-Price, R. K. Johnson, A. J. Giovenella, L. F. Faucette, C. K. Mirabelli, and P. J. Sadler, J. Inorg. Biochem., 33, 285 (1988).
16. e) K. Nomiya, R. Noguchi, and M. Oda, Inorg. Chim. Acta, 298, 24 (2000).
17. f) K. Nomiya, R. Noguchi, T. Shigeta, Y. Kondoh, K. Tsuda, K. Ohsawa, N. C. Kasuga, and M. Oda, Bull. Chem. Soc. Jpn., 73, 1143 (2000).
18. g) K. Nomiya, R. Noguchi, K. Ohsawa, K. Tsuda, and M. Oda, J. Inorg. Biochem., 78, 363 (2000).
19. a) H. Veen and A. A. M. Kwakkenbos, Sci. Hortic. (Amsterdam), 18, 277 (1982, 1983).
20. b) H. Veen, Sci. Hortic. (Amsterdam), 20, 211 (1983).
21. c) K. M. Davies, G. E. Hobson, and D. Grierson, Plant Cell Environ., 11, 729 (1988).
22. a) R. B. Thurman and C. P. Gerba, CRC Crit. Rev. Environ. Control, 18, 295 (1989).
23. b) R. Lopez-Garzon, M. A. Romero-Molina, A. Navarrete-Guijosa, J. M. Lopez-Gonzalez, G. Alvarez-Cienfuegos, and M. M. Herrador-Pino, J. Inorg. Biochem., 38, 139 (1990).
24. Q. L. Feng, J. Wu, G. Q. Chen, F. Z. Cui, T. N. Kim, and J. O. Kim, J. Biomed. Mater. Res., 52, 662 (2000).
25. A. D. Russell and W. B. Hugo, Prog. Med. Chem., 31, 351 (1994).
26. e) J. L. Clement and P. S. Jarrett, Met.-Based Drugs, 1, 467 (1994).
27. f) R. M. E. Richards, R. B. Taylor, and D. K. L. Xing, J. Pharm. Sci., 80, 861 (1991).
28. a) K. Nomiya, S. Takahashi, R. Noguchi, S. Nemoto, T. Takayama, and M. Oda, Inorg. Chem., 39, 3301 (2000).
29. b) K. Nomiya, S. Takahashi, and R. Noguchi, J. Chem. Soc., Dalton Trans., 2000, 4369.
30. K. Nomiya, S. Takahashi, and R. Noguchi, J. Chem. Soc., Dalton Trans., 2000, 1343.
31. K. Nomiya and H. Yokoyama, J. Chem. Soc., Dalton Trans., 2002, 2483.
32. e) N. C. Kasuga, A. Sugie, and K. Nomiya, Dalton Trans., 2004, 3732.
33. f) R. Noguchi, A. Hara, A. Sugie, S. Tanabe, and K. Nomiya, Chem. Lett., 34, 578 (2005).
34. g) R. Noguchi, A. Hara, A. Sugie, and K. Nomiya, under submission.
35. G. M. Sheldrick, "SHELXL, version 5.1," Bruker Analytical X-ray System, Inc., Madison, WI (1997).
36. R. Alessio, D. B. Dell'Amico, F. Calderazzo, U. Englert, A. Guarini, L. Labella, and P. Strasser, Helv. Chim. Acta, 81, 219 (1998).
37. G. A. Bowmaker, E. N. de Silva, P. C. Healy, B. W. Skelton, and A. H. White, J. Chem. Soc., Dalton Trans., 1999, 901.